WVE Q2 2025 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-55.8% YoY

Gross Profit

$7M74.8% margin

Operating Income

-$53M-606.5% margin

Net Income

-$50M-580.2% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-5.2%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$252M

Total Liabilities

$113M

Stockholders' Equity

$139M

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$20M	-55.8%
Gross Profit	$7M	$20M	-67.0%
Operating Income	-$53M	-$35M	-50.8%
Net Income	-$50M	-$33M	-53.3%